Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

9amHealth vs Dr. Gillis' Wellness Center

9amHealth
Graded #93

Higher grade

vs+4.299999999999997
Dr. Gillis' Wellness Center
Graded #169

Lower grade

The verdict

9amHealth takes it — 71.3/100 to 67/100.

9amHealth grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. 9amHealth (join9am.com) is a cardiometabolic telehealth platform offering whole-body care including weight management with FDA-approved branded GLP-1 medications such as Wegovy, Zepbound, and Saxenda, plus…

We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost value9amHealth +4
68
64
Dose & formulationDr. Gillis' Wellness Center +3
65
68
Clinical oversight9amHealth +4
88
84
Labs & monitoring9amHealth +21
74
53
FulfillmentDr. Gillis' Wellness Center +13
68
81
Contract terms9amHealth +18
55
37
9amHealth · left barDr. Gillis' Wellness Center · right bar

The numbers

Metric9amHealthDr. Gillis' Wellness Center
WeighScore71.3/10067/100
GradeCC
Scorecard rank#93#169
Semaglutide$149/mo (plus a separate fee, brand-name)$149/mo (starting dose, compounded)
TirzepatideNot disclosedNot disclosed
CoverageCoverage not publishedAll 50 states
Brand-name accessYesCompounded only
Oral / sublingualInjection onlyYes
9amHealth

Graded #93 · C

Strengths

  • Prescribes FDA-approved branded GLP-1s (Wegovy, Zepbound, Saxenda)
  • $149/month membership or free when covered by insurance
  • Membership includes specialists, labs, devices, and medications
  • Board-certified obesity specialists (DABOM), endocrinologists, dietitians, PharmDs
  • Helps navigate insurance approvals; employer and state-plan partnerships

Where it loses points

  • Medication coverage and GLP-1 access depend on insurance and BMI criteria
  • State availability not enumerated on the public site
  • Branded GLP-1s can be costly without insurance coverage
  • Pricing for medications not transparently listed

Strengths

  • Sublingual ODT tablets offered as needle-free alternative
  • Broad GLP-1 menu: semaglutide, tirzepatide, and retatrutide
  • Transparent pricing: $150 starting dose, plans from $149/mo
  • Led by board-certified physician/surgeon with 25+ years experience
  • No contracts; flexible weekly, bi-weekly, or monthly cadence

Where it loses points

  • Specific dose-tier pricing beyond starting plan not detailed
  • Compounded vs brand not explicitly stated for all meds
  • Smaller clinic vs national telehealth brands
  • State licensing list not published

Also worth a look

Neither is our top-graded pick — CoreAge Rx leads the scorecard

Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard